These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Interventions for the long-term prevention of hereditary angioedema attacks. Beard N, Frese M, Smertina E, Mere P, Katelaris C, Mills K. Cochrane Database Syst Rev; 2022 Nov 03; 11(11):CD013403. PubMed ID: 36326435 [Abstract] [Full Text] [Related]
8. Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema. Lumry W, Soteres D, Gower R, Jacobson KW, Li HH, Chen H, Schranz J. Pediatr Allergy Immunol; 2015 Nov 03; 26(7):674-80. PubMed ID: 26171584 [Abstract] [Full Text] [Related]
9. Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children. Lumry W, Manning ME, Hurewitz DS, Davis-Lorton M, Fitts D, Kalfus IN, Uknis ME. J Pediatr; 2013 May 03; 162(5):1017-22.e1-2. PubMed ID: 23312695 [Abstract] [Full Text] [Related]
11. Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert® (C1-INH) Registry. Bygum A, Martinez-Saguer I, Bas M, Rosch J, Edelman J, Rojavin M, Williams-Herman D, Berinert Registry Investigators. Drugs Aging; 2016 Nov 03; 33(11):819-827. PubMed ID: 27699634 [Abstract] [Full Text] [Related]
16. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children. Reshef A, Grivcheva-Panovska V, Kessel A, Kivity S, Klimaszewska-Rembiasz M, Moldovan D, Farkas H, Gutova V, Fritz S, Relan A, Giannetti B, Magerl M. Pediatr Allergy Immunol; 2019 Aug 03; 30(5):562-568. PubMed ID: 30993784 [Abstract] [Full Text] [Related]